Clinical trial
A Double Blind Comparison of Omacor and Placebo as Secondary Prevention Against Cardiovascular Events in Patients Undergoing Chronic Hemodialysis
NCT00257283 is registered in ClinicalTrials.gov with Pronova BioPharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double Blind Comparison of Omacor and Placebo as Secondary Prevention Against Cardiovascular Events in Patients Undergoing Chronic Hemodialysis
- Lead sponsor
- Pronova BioPharma
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2002
- Completion date
- June 30, 2005
- Enrollment
- 200
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.